- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 9/48 - Hydrolases (3.) acting on peptide bonds, e.g. thromboplastin, leucine aminopeptidase (3.4)
Patent holdings for IPC class C12N 9/48
Total number of patents in this class: 872
10-year publication summary
|
42
|
40
|
57
|
44
|
68
|
92
|
84
|
94
|
47
|
9
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novozymes A/S | 3350 |
27 |
| The Trustees of the University of Pennsylvania | 4405 |
17 |
| Centre National de La Recherche Scientifique | 10841 |
14 |
| Regeneron Pharmaceuticals, Inc. | 4571 |
14 |
| Northwestern University | 3504 |
13 |
| The Regents of the University of California | 20473 |
11 |
| Formycon AG | 40 |
10 |
| Commissariat à l'énergie atomique et aux energies alternatives | 10983 |
8 |
| DuPont Nutrition Biosciences ApS | 473 |
8 |
| Spogen Biotech Inc. | 145 |
8 |
| Encodia, Inc. | 103 |
8 |
| University of Florida Research Foundation, Inc. | 4134 |
7 |
| Danisco US Inc. | 1131 |
7 |
| Health Research, Inc. | 344 |
7 |
| Universite Grenoble Alpes | 766 |
7 |
| DSM IP Assets B.V. | 5457 |
6 |
| Ajinomoto Co., Inc. | 2299 |
6 |
| The Children's Hospital of Philadelphia | 833 |
6 |
| Dana-Farber Cancer Institute, Inc. | 2642 |
6 |
| Renescience A/S | 38 |
6 |
| Other owners | 676 |